Fermenta Biotech Limited Share Price & Analysis
₹335.15▲ +4.77%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹335.15
+4.77%
Open
₹—
High
₹345
Low
₹315.4
Close
₹335.15
52W High
₹399
52W Low
₹249
Volume
75K
Lot Size
1
Sector
Healthcare
Market Cap
₹922 Cr
Face Value
₹5
Small Cap
Price Chart
Fundamentals
P/E
13.8
Sector P/E
48.9
P/B
2.43
EPS
₹29.55
ROE
17.4%
ROCE
20.4%
D/E Ratio
0.28
Div Yield
0.8%
Book Value
₹138
+
Strengths
- ✓Strong return on equity (ROE 17.4%)
- ✓Efficient capital deployment (ROCE 20.4%)
- ✓Attractively valued vs sector (P/E 13.8x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
FERMENTA · as of Mar 2026
Promoters64.08%▲2.02
FII0.02%
Public35.00%▼1.98
Others0.89%▼0.05
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 62.06% | 62.06% | 62.06% | 62.06% | 62.06% | 64.08% |
| FII | — | — | — | 0.05% | 0.02% | 0.02% |
| Public | 36.05% | 36.05% | 36.11% | 36.41% | 36.98% | 35.00% |
| Others | 1.89% | 1.89% | 1.82% | 1.47% | 0.94% | 0.89% |
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹137 Cr ▲5.4% | ₹130 Cr ▼4.4% | ₹136 Cr ▼2.9% | ₹140 Cr ▼10.3% | ₹156 Cr ▲64.2% | ₹95 Cr ▲21.8% | ₹78 Cr ▼19.6% | ₹97 Cr |
| Op. Profit | ₹25 Cr ▼7.4% | ₹27 Cr ▼3.6% | ₹28 Cr ▼24.3% | ₹37 Cr ▼30.2% | ₹53 Cr ▲178.9% | ₹19 Cr ▲1800.0% | ₹1 Cr ▼80.0% | ₹5 Cr |
| OPM | 18.0% ▼10.0% | 20.0% ▼4.8% | 21.0% ▼19.2% | 26.0% ▼23.5% | 34.0% ▲70.0% | 20.0% ▲1900.0% | 1.0% ▼83.3% | 6.0% |
| Net Profit | ₹12 Cr ▼33.3% | ₹18 Cr ▼18.2% | ₹22 Cr ▼33.3% | ₹33 Cr ▼13.2% | ₹38 Cr ▲245.5% | ₹11 Cr ▲283.3% | ₹-6 Cr ▲14.3% | ₹-7 Cr |
| EPS (₹) | 4.31 ▼29.8% | 6.14 ▼17.3% | 7.42 ▼36.5% | 11.68 ▼6.9% | 12.54 ▲224.0% | 3.87 ▲295.5% | -1.98 ▲16.1% | -2.36 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹525 Cr ▲12.2% | ₹468 Cr ▲39.7% | ₹335 Cr ▼4.0% | ₹349 Cr ▼12.1% | ₹397 Cr ▲5.6% | ₹376 Cr ▲28.8% | ₹292 Cr ▼27.5% | ₹403 Cr ▲33.4% | ₹302 Cr ▲84.1% | ₹164 Cr |
| Expenses | ₹426 Cr ▲21.0% | ₹352 Cr ▲14.7% | ₹307 Cr ▼7.0% | ₹330 Cr ▼1.5% | ₹335 Cr ▲14.3% | ₹293 Cr ▲30.2% | ₹225 Cr ▼9.3% | ₹248 Cr ▲18.7% | ₹209 Cr ▲37.5% | ₹152 Cr |
| Op. Profit | ₹100 Cr ▼13.0% | ₹115 Cr ▲310.7% | ₹28 Cr ▲55.6% | ₹18 Cr ▼71.0% | ₹62 Cr ▼25.3% | ₹83 Cr ▲25.8% | ₹66 Cr ▼57.7% | ₹156 Cr ▲67.7% | ₹93 Cr ▲675.0% | ₹12 Cr |
| OPM | 19.0% ▼24.0% | 25.0% ▲212.5% | 8.0% ▲60.0% | 5.0% ▼68.8% | 16.0% ▼27.3% | 22.0% ▼4.3% | 23.0% ▼41.0% | 39.0% ▲25.8% | 31.0% ▲342.9% | 7.0% |
| Other Income | ₹29 Cr ▲314.3% | ₹7 Cr ▲75.0% | ₹4 Cr ▲120.0% | ₹-20 Cr ▼350.0% | ₹8 Cr ▲0.0% | ₹8 Cr ▼33.3% | ₹12 Cr ▲100.0% | ₹6 Cr ▼33.3% | ₹9 Cr ▲200.0% | ₹3 Cr |
| Interest | ₹12 Cr ▼20.0% | ₹15 Cr ▼11.8% | ₹17 Cr ▼19.0% | ₹21 Cr ▲16.7% | ₹18 Cr ▼5.3% | ₹19 Cr ▼5.0% | ₹20 Cr ▼4.8% | ₹21 Cr ▲50.0% | ₹14 Cr ▲40.0% | ₹10 Cr |
| Depreciation | ₹22 Cr ▼8.3% | ₹24 Cr ▼4.0% | ₹25 Cr ▼10.7% | ₹28 Cr ▲7.7% | ₹26 Cr ▲30.0% | ₹20 Cr ▲33.3% | ₹15 Cr ▲25.0% | ₹12 Cr ▲0.0% | ₹12 Cr ▲20.0% | ₹10 Cr |
| PBT | ₹96 Cr ▲15.7% | ₹83 Cr ▲930.0% | ₹-10 Cr ▲80.4% | ₹-51 Cr ▼288.9% | ₹27 Cr ▼48.1% | ₹52 Cr ▲20.9% | ₹43 Cr ▼66.7% | ₹129 Cr ▲69.7% | ₹76 Cr ▲1366.7% | ₹-6 Cr |
| Tax % | 27.0% ▲237.5% | 8.0% ▼94.4% | 143.0% ▲3475.0% | 4.0% ▼90.9% | 44.0% ▲144.4% | 18.0% ▲148.6% | -37.0% ▼562.5% | 8.0% ▼71.4% | 28.0% ▼42.9% | 49.0% |
| Net Profit | ₹70 Cr ▼7.9% | ₹76 Cr ▲416.7% | ₹-24 Cr ▲54.7% | ₹-53 Cr ▼453.3% | ₹15 Cr ▼65.1% | ₹43 Cr ▼28.3% | ₹60 Cr ▼48.7% | ₹117 Cr ▲154.3% | ₹46 Cr ▲611.1% | ₹-9 Cr |
| EPS (₹) | 24.39 ▼6.6% | 26.12 ▲433.2% | -7.84 ▲54.8% | -17.36 ▼430.7% | 5.25 ▼66.0% | 15.46 ▼23.6% | 20.23 ▼52.6% | 42.71 ▲249.8% | 12.21 ▲394.9% | -4.14 |
| Div Payout | 15.0% ▲66.7% | 9.0% ▲156.3% | -16.0% ▼128.6% | -7.0% ▼130.4% | 23.0% ▲43.8% | 16.0% ▼33.3% | 24.0% ▲2300.0% | 1.0% ▼50.0% | 2.0% ▲140.0% | -5.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹15 Cr ▲0.0% | ₹15 Cr ▲7.1% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲180.0% | ₹5 Cr ▲150.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| Reserves | ₹376 Cr ▲8.0% | ₹348 Cr ▲27.0% | ₹274 Cr ▼9.0% | ₹301 Cr ▼15.9% | ₹358 Cr ▲3.5% | ₹346 Cr ▲17.3% | ₹295 Cr ▲19.9% | ₹246 Cr ▲101.6% | ₹122 Cr ▼14.1% | ₹142 Cr |
| Borrowings | ₹112 Cr ▼2.6% | ₹115 Cr ▼17.3% | ₹139 Cr ▼36.8% | ₹220 Cr ▼7.9% | ₹239 Cr ▲3.0% | ₹232 Cr ▲3.6% | ₹224 Cr ▲7.2% | ₹209 Cr ▲20.8% | ₹173 Cr ▲98.9% | ₹87 Cr |
| Other Liabilities | ₹149 Cr ▲8.8% | ₹137 Cr ▲14.2% | ₹120 Cr ▲17.6% | ₹102 Cr ▲6.3% | ₹96 Cr ▲2.1% | ₹94 Cr ▲17.5% | ₹80 Cr ▼13.0% | ₹92 Cr ▲5.7% | ₹87 Cr ▲16.0% | ₹75 Cr |
| Total Liabilities | ₹651 Cr ▲6.0% | ₹614 Cr ▲12.0% | ₹548 Cr ▼14.0% | ₹637 Cr ▼9.9% | ₹707 Cr ▲2.9% | ₹687 Cr ▲11.9% | ₹614 Cr ▲11.4% | ₹551 Cr ▲43.1% | ₹385 Cr ▲25.4% | ₹307 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹219 Cr ▼3.5% | ₹227 Cr ▼15.6% | ₹269 Cr ▲0.7% | ₹267 Cr ▼10.7% | ₹299 Cr ▲13.7% | ₹263 Cr ▲31.5% | ₹200 Cr ▲12.4% | ₹178 Cr ▲0.6% | ₹177 Cr ▲2.9% | ₹172 Cr |
| CWIP | ₹26 Cr ▲62.5% | ₹16 Cr ▲700.0% | ₹2 Cr ▼95.6% | ₹45 Cr ▲28.6% | ₹35 Cr ▼38.6% | ₹57 Cr ▼19.7% | ₹71 Cr ▲222.7% | ₹22 Cr ▲450.0% | ₹4 Cr ▼20.0% | ₹5 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹8 Cr ▼20.0% | ₹10 Cr ▼44.4% | ₹18 Cr |
| Other Assets | ₹406 Cr ▲9.1% | ₹372 Cr ▲34.3% | ₹277 Cr ▼13.7% | ₹321 Cr ▼13.9% | ₹373 Cr ▲1.6% | ₹367 Cr ▲7.3% | ₹342 Cr ▼0.6% | ₹344 Cr ▲78.2% | ₹193 Cr ▲72.3% | ₹112 Cr |
| Total Assets | ₹651 Cr ▲6.0% | ₹614 Cr ▲12.0% | ₹548 Cr ▼14.0% | ₹637 Cr ▼9.9% | ₹707 Cr ▲2.9% | ₹687 Cr ▲11.9% | ₹614 Cr ▲11.4% | ₹551 Cr ▲43.1% | ₹385 Cr ▲25.4% | ₹307 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹41 Cr ▼61.0% | ₹105 Cr ▼9.5% | ₹116 Cr ▲169.8% | ₹43 Cr ▼31.7% | ₹63 Cr ▲85.3% | ₹34 Cr ▼62.2% | ₹90 Cr ▲52.5% | ₹59 Cr ▲2850.0% | ₹2 Cr ▼50.0% | ₹4 Cr |
| Investing CF | ₹0 Cr ▲100.0% | ₹-16 Cr ▲70.9% | ₹-55 Cr ▼111.5% | ₹-26 Cr ▲36.6% | ₹-41 Cr ▲6.8% | ₹-44 Cr ▲54.6% | ₹-97 Cr ▲4.0% | ₹-101 Cr ▼1542.9% | ₹7 Cr ▲153.8% | ₹-13 Cr |
| Financing CF | ₹-51 Cr ▲44.0% | ₹-91 Cr ▼122.0% | ₹-41 Cr ▼86.4% | ₹-22 Cr ▼2100.0% | ₹-1 Cr ▲97.9% | ₹-47 Cr ▼491.7% | ₹12 Cr ▼86.5% | ₹89 Cr ▲841.7% | ₹-12 Cr ▼220.0% | ₹10 Cr |
| Net Cash Flow | ₹-10 Cr ▼900.0% | ₹-1 Cr ▼105.3% | ₹19 Cr ▲575.0% | ₹-4 Cr ▼119.0% | ₹21 Cr ▲136.8% | ₹-57 Cr ▼1050.0% | ₹6 Cr ▼87.2% | ₹47 Cr ▲1275.0% | ₹-4 Cr ▼500.0% | ₹1 Cr |
| Free Cash Flow | ₹38 Cr ▼55.8% | ₹86 Cr ▲13.2% | ₹76 Cr ▲1166.7% | ₹6 Cr ▼14.3% | ₹7 Cr ▲120.6% | ₹-34 Cr ▼161.8% | ₹55 Cr ▲31.0% | ₹42 Cr ▲347.1% | ₹-17 Cr ▲32.0% | ₹-25 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 74d ▼2.6% | 76d ▲72.7% | 44d ▼45.0% | 80d ▲21.2% | 66d ▼24.1% | 87d ▲47.5% | 59d ▼28.9% | 83d ▼16.2% | 99d ▼2.0% | 101d |
| Inventory Days | 306d ▲24.9% | 245d ▼20.7% | 309d ▼18.7% | 380d ▼13.8% | 441d ▼25.8% | 594d ▲71.2% | 347d ▲48.3% | 234d ▲12.5% | 208d ▲30.0% | 160d |
| Days Payable | 192d ▲5.5% | 182d ▲67.0% | 109d ▼29.2% | 154d ▼8.9% | 169d ▼35.0% | 260d ▲53.8% | 169d ▼7.7% | 183d ▲24.5% | 147d ▲30.1% | 113d |
| Cash Conv. Cycle | 189d ▲36.0% | 139d ▼43.0% | 244d ▼20.3% | 306d ▼9.5% | 338d ▼19.7% | 421d ▲77.6% | 237d ▲76.9% | 134d ▼16.3% | 160d ▲8.1% | 148d |
| Working Capital Days | 40d ▲344.4% | 9d ▲150.0% | -18d ▼126.9% | 67d ▲24.1% | 54d ▼22.9% | 70d ▲62.8% | 43d ▼20.4% | 54d ▲63.6% | 33d ▲167.3% | -49d |
| ROCE | 23.0% ▲666.7% | 3.0% | 0.0% ▼100.0% | 7.0% ▼46.2% | 13.0% ▲8.3% | 12.0% ▼70.7% | 41.0% ▲32.3% | 31.0% ▲1450.0% | 2.0% ▼66.7% | 6.0% |
Source: Screener.in · Lower days = better efficiency
About Fermenta Biotech Limited
Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Fermenta Biotech Limited share price today?▾
Fermenta Biotech Limited (FERMENTA) is currently trading at ₹335.15 on NSE, up 4.77% as of the last market session. Prices update daily after market close on MarketNetra.
Is Fermenta Biotech Limited available in F&O (Futures & Options)?▾
Yes, Fermenta Biotech Limited (FERMENTA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Fermenta Biotech Limited 52-week high and low?▾
Fermenta Biotech Limited's 52-week high is ₹399 and the 52-week low is ₹249. The current price of ₹335.15 is 16.0% below the 52W high.
What is Fermenta Biotech Limited P/E ratio?▾
Fermenta Biotech Limited's current P/E ratio is 13.8. This indicates the market is paying ₹13.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Fermenta Biotech Limited options?▾
Fermenta Biotech Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade FERMENTA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.